Alpha Tau Medical (DRTS) vs UFP Technologies (UFPT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alpha Tau Medical (DRTS) has outperformed UFP Technologies (UFPT) over the past year, gaining 245.0% versus a gain of 48.7%. Over five years, UFPT leads with a +358.9% price change compared with +44.1% for DRTS. UFP Technologies is the larger company by market cap ($2.22 billion vs $1.29 billion), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRTS | UFPT |
|---|---|---|
| Share price | $14.00 | $286.56 |
| Market cap | $1.29B | $2.22B |
| 1-day change | -1.75% | -2.15% |
| YTD return | +187.88% | +31.91% |
| 1-year return | +245.04% | +48.68% |
| 5-year return | +44.08% | +358.90% |
| P/E ratio (TTM) | — | 30.95 |
| Forward P/E | — | 24.14 |
| EPS (TTM) | $-1.04 | $9.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.79 | $338.71 |
| 52-week low | $3.43 | $173.86 |
| Distance from 52-week high | -11.34% | -15.40% |
| Analyst consensus | none | none |
| Avg. price target upside | +27.14% | +23.88% |
| Average volume | 566.95K | 157.18K |
| Shares outstanding | 92.48M | 7.75M |
| Employees | 121 | 4,846 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DRTS has outperformed UFPT by 196.4 percentage points over the past year.
About Alpha Tau Medical
DRTS stock →Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Health Care · Medical/Dental Instruments · 121 employees
About UFP Technologies
UFPT stock →UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing.
Health Care · Medical/Dental Instruments · 4,846 employees
DRTS vs UFPT FAQ
Which is bigger, Alpha Tau Medical or UFP Technologies?
UFP Technologies (UFPT) is larger, with a market capitalization of $2.22B compared with $1.29B for Alpha Tau Medical (DRTS).
Which stock has performed better over the past year, DRTS or UFPT?
DRTS returned +245.04% over the past 12 months, compared with +48.68% for UFPT (price return, excluding dividends). Past performance does not predict future results.
Are Alpha Tau Medical and UFP Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.